These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study. Resino S, Bellón JM, Ramos JT, Gonzalez-Rivera M, de José MI, González MI, Gurbindo D, Mellado MJ, Cabrero E, Muñoz-Fernández MA. J Antimicrob Chemother; 2004 Nov; 54(5):921-31. PubMed ID: 15472006 [Abstract] [Full Text] [Related]
6. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, Johnson M, Johnson D, Lalonde R, Japour A, Brun S, Sun E, M98-863 Study Team. N Engl J Med; 2002 Jun 27; 346(26):2039-46. PubMed ID: 12087139 [Abstract] [Full Text] [Related]
7. Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice. Moltó J, Santos JR, Negredo E, Miranda C, Videla S, Clotet B. J Antimicrob Chemother; 2007 Aug 27; 60(2):436-9. PubMed ID: 17556354 [Abstract] [Full Text] [Related]
8. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children. Larrú B, Resino S, Bellón JM, de José MI, Fortuny C, Navarro ML, Gurbindo MD, Ramos JT, Soler Palacín P, Léon JA, Asensi M, Mellado MJ, Muñoz-Fernández MA. J Antimicrob Chemother; 2008 Jan 27; 61(1):183-90. PubMed ID: 18025025 [Abstract] [Full Text] [Related]